Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FREELAND G OLIVERIO

Allopathic & Osteopathic Physicians Family Medicine

NPI
1578562013
CMS profile
70805
Location
DOYLESTOWN, OH

General Payments · PY2018–2020

$748.46

  • Reported across 86 records
  • CMS publication 2026-01-23

Latest program year · PY2020

$274.64

41 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2020 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $263.08 40
Education $11.56 1

By paying entity

PY2020 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $224.08 38
Endo Pharmaceuticals Inc. $22.14 1
ORGANOGENESIS INC. $16.86 1
Acerta Pharma LLC $11.56 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $354.88 24
PY2019 $118.94 21
PY2020 $274.64 41

Payment records · PY2020 (41)

Sorted by paying entity, then date · as published by CMS

Program year 2020 20182019 Record-level detail is published for PY2020; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $11.56 10/05/2020 Education Undisputed 01/23/2026 736032391 CMS
Endo Pharmaceuticals Inc. $22.14 09/08/2020 Food and Beverage Undisputed 01/23/2026 736530605 CMS
Novo Nordisk Inc $6.71 01/09/2020 Food and Beverage Undisputed 01/23/2026 744564245 CMS
Novo Nordisk Inc $4.04 01/14/2020 Food and Beverage Undisputed 01/23/2026 744571035 CMS
Novo Nordisk Inc $12.75 01/16/2020 Food and Beverage Undisputed 01/23/2026 744571029 CMS
Novo Nordisk Inc $5.22 01/22/2020 Food and Beverage Undisputed 01/23/2026 744599027 CMS
Novo Nordisk Inc $6.32 01/23/2020 Food and Beverage Undisputed 01/23/2026 744569645 CMS
Novo Nordisk Inc $6.15 01/23/2020 Food and Beverage Undisputed 01/23/2026 744598995 CMS
Novo Nordisk Inc $5.48 02/04/2020 Food and Beverage Undisputed 01/23/2026 744569651 CMS
Novo Nordisk Inc $5.25 02/06/2020 Food and Beverage Undisputed 01/23/2026 744599077 CMS
Novo Nordisk Inc $5.48 02/13/2020 Food and Beverage Undisputed 01/23/2026 750047059 CMS
Novo Nordisk Inc $2.14 02/13/2020 Food and Beverage Undisputed 01/23/2026 856608257 CMS
Novo Nordisk Inc $10.68 02/14/2020 Food and Beverage Undisputed 01/23/2026 744608707 CMS
Novo Nordisk Inc $4.80 02/20/2020 Food and Beverage Undisputed 01/23/2026 744608663 CMS
Novo Nordisk Inc $8.43 03/06/2020 Food and Beverage Undisputed 01/23/2026 744637425 CMS
Novo Nordisk Inc $7.75 03/12/2020 Food and Beverage Undisputed 01/23/2026 744640091 CMS
Novo Nordisk Inc $9.09 05/01/2020 Food and Beverage Undisputed 01/23/2026 744679489 CMS
Novo Nordisk Inc $10.58 05/08/2020 Food and Beverage Undisputed 01/23/2026 744713953 CMS
Novo Nordisk Inc $8.94 05/20/2020 Food and Beverage Undisputed 01/23/2026 744713957 CMS
Novo Nordisk Inc $7.07 06/03/2020 Food and Beverage Undisputed 01/23/2026 744773625 CMS
Novo Nordisk Inc $5.04 06/15/2020 Food and Beverage Undisputed 01/23/2026 744773629 CMS
Novo Nordisk Inc $4.99 06/19/2020 Food and Beverage Undisputed 01/23/2026 744749897 CMS
Novo Nordisk Inc $7.83 06/25/2020 Food and Beverage Undisputed 01/23/2026 744791465 CMS
Novo Nordisk Inc $6.60 07/02/2020 Food and Beverage Undisputed 01/23/2026 744792611 CMS
Novo Nordisk Inc $6.38 07/13/2020 Food and Beverage Undisputed 01/23/2026 744792629 CMS
Novo Nordisk Inc $5.31 07/17/2020 Food and Beverage Undisputed 01/23/2026 744806255 CMS
Novo Nordisk Inc $3.76 08/04/2020 Food and Beverage Undisputed 01/23/2026 744842845 CMS
Novo Nordisk Inc $3.42 08/20/2020 Food and Beverage Undisputed 01/23/2026 744887403 CMS
Novo Nordisk Inc $4.68 08/26/2020 Food and Beverage Undisputed 01/23/2026 744887407 CMS
Novo Nordisk Inc $7.91 09/02/2020 Food and Beverage Undisputed 01/23/2026 744871413 CMS
Novo Nordisk Inc $4.73 09/10/2020 Food and Beverage Undisputed 01/23/2026 744871427 CMS
Novo Nordisk Inc $2.00 09/11/2020 Food and Beverage Undisputed 01/23/2026 744897221 CMS
Novo Nordisk Inc $5.03 09/21/2020 Food and Beverage Undisputed 01/23/2026 744895339 CMS
Novo Nordisk Inc $4.80 10/05/2020 Food and Beverage Undisputed 01/23/2026 744935967 CMS
Novo Nordisk Inc $4.14 10/12/2020 Food and Beverage Undisputed 01/23/2026 744935977 CMS
Novo Nordisk Inc $3.08 10/15/2020 Food and Beverage Undisputed 01/23/2026 744928125 CMS
Novo Nordisk Inc $5.14 10/15/2020 Food and Beverage Undisputed 01/23/2026 744928127 CMS
Novo Nordisk Inc $4.12 10/26/2020 Food and Beverage Undisputed 01/23/2026 744955455 CMS
Novo Nordisk Inc $2.24 11/03/2020 Food and Beverage Undisputed 01/23/2026 745002139 CMS
Novo Nordisk Inc $6.00 11/03/2020 Food and Beverage Undisputed 01/23/2026 745002141 CMS
ORGANOGENESIS INC. $16.86 09/24/2020 Food and Beverage Undisputed 01/23/2026 750631257 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020
Generated from
OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.